PET Myocardial Blood Flow Biomarker Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
| Line 12: | Line 12: | ||
==Meetings== | ==Meetings== | ||
*[[Media:2022_02-28_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 28, 2022]] | |||
*[[Media:2022_02-14_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 14, 2022]] | |||
*[[Media:2022_01-24_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 24, 2022]] | *[[Media:2022_01-24_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 24, 2022]] | ||
*[[Media:2021_12-13_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|December 13, 2021]] | *[[Media:2021_12-13_QIBA_PET_MBF_Biomarker_Ctte_Call_Summary_FINAL.pdf|December 13, 2021]] | ||
Revision as of 18:12, 14 February 2022
- Co-chairs: Robert deKemp, PhD; Marcelo Di Carli, MD; Jonathan B. Moody, PhD
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
Develop a quantitative imaging Profile for PET Myocardial Blood Flow.
This effort uses the QIBA Process for Profile development.
Meetings
PET Myocardial Blood Flow Call Summaries Archive